LinKinVax and Inserm Transfert Enter Into an Exclusive World

LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of

Related Keywords

Paris , France General , France , French , Inserm Universit , Jacques Auberton Herv , Inserm Transfert , Corinne Margot , Annie Florence Loyer , Inserm Transfert Initiative , Mondor Institute For Biomedical Research , Service Public , Research Inserm , Vaccine Research Institute Inserm , Research Unit , Vaccine Research Institute , University Of Paris Est Cr , Public Service Management Contract , Baylor Scott White Research Institute , French National Institute Of The Health , Dendritic Cells , Mondor Institute , Biomedical Research , Vaccine Research , Pascale Aug , Executive Management Board , Honorary Chairman , Yves Levy , French National Institute , Medical Research , Florence Loyer , Linkinvax , Inserm , Transfert , Winter , Into , Exclusive , Orldwide , Icensing , Agreement , Covering , Nnovative , Vaccine , Platform ,